– UK, Sheffield – Benchmark (AIM:BMK), the aquaculture biotechnology and food chain sustainability business, announces the appointment of Kevin Quinn as a Non-Executive Director of the Company with immediate effect.
Kevin Quinn (56) has over 30 years of financial experience in international business and the biosciences industry, including with FTSE 100 companies. Kevin has for the past 11 years been Chief Financial Officer at Berendsen plc, the leading FTSE 250 European textile service business. Previously, Kevin held senior finance positions within biosciences group Amersham plc and before that was a partner with PricewaterhouseCoopers (Prague).
Kevin will Chair the Audit Committee and sit on the Remuneration Committee. He will stand for re-election by shareholders at the next Annual General Meeting.
Benchmark’s Chairman, Alex Hambro, commented: “We are delighted to welcome Kevin to the Board of Benchmark. His skills and experience in large international companies will prove especially valuable as Benchmark continues to integrate and grow its global aquaculture offering, and his industry experience in biosciences is highly relevant.
Kevin is taking the position formerly held by Basil Brookes, who stepped down in July, and who we thank again for his exceptional contribution to the Board.”
The company has proven distribution capabilities in high growth markets and through these it provides world leading: Products – through an integrated package of high genetic merit breeding stock, next era vaccines, pharmaceuticals and biocides and advanced nutrition diets for the early stages of production. Manufacturing – delivering cutting-edge technologies in animal health vaccines, aquaculture breeding production facilities /technology and state-of-the-art advanced nutrition product manufacturing. Services – from veterinary clinical and diagnostic to technical in field/on farm support and genetic programme management. Knowledge – through consultancy, professional training, technical online & book publishing and data management systems. Research – into major health and management challenges facing aquaculture, agriculture and animal health care informing the development of the group’s medicines, vaccines and management technologies.
Benchmark operates internationally with offices in England, Scotland, Belgium, Ireland, Norway, Iceland, USA, Brazil, China, Russia, Portugal, Thailand and Chile. As at 31 October 2016, Benchmark employed 891 people.
For more information : http://www.benchmarkplc.com
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.